Clinical Trial Update: A Research Study to See How Safe is Eptacog Alfa When Used to Stop Heavy Bleeding in Women After Giving Birth in India [Phase 4]

View source ↗

Summary

Phase 4 clinical trial in India is evaluating the safety of Eptacog alfa to stop heavy bleeding in women after childbirth; the study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Postpartum Hemorrhage

Drugs mentioned

• Eptacog alfa (recombinant activated coagulation factor VII)

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Severe Postpartum Haemorrhage | Phase 4 | Status: RECRUITING